Major executive appointments for radiology-AI company

Latest News

Radiology and artificial intelligence company Annalise.ai has announced the appointment of two key executives.

The company said Lakshmi Gudapakkam is its new chief executive officer and clinical strategist while Dr Rick Abramson is its new chief medical officer.

Annalise.ai combines artificial intelligence (AI) with clinical expertise. The company was formed in 2019 as a joint venture between healthcare AI platform harrison.ai and I-MED Radiology Network, Australia’s largest diagnostic imaging network.

The company said the new appointments will support the further acceleration in its local and global market presence, including entry to the US following recent FDA approvals for part of its comprehensive radiology AI product.

Mr Gudapakkam previously served in senior global technology and business leadership roles in GE Healthcare and Philips Healthcare and for the last four years with Quest Diagnostics, as their vice president and general manager for their East Region.

During his time with GE Healthcare, Mr Gudapakkam led large global teams across the US, Canada, Europe, India, China and Australia.

As chief medical officer, Dr Abramson will be responsible for guiding the company’s clinical roadmap for international expansion.

A US-based physician leader and board-certified radiologist, Dr Abramson brings more than 25 years of experience in healthcare including prior roles in clinical practice, academic research, policy development, and management.

Both Mr Gudapakkam and Dr Abramson will be based in the US.

“To meet the growing demands on our global healthcare system, we need smart tools that help specialists diagnose and treat patients more effectively and accurately," said Mr Gudapakkam.

"The team at annalise.ai have shown an astounding ability to not only provide this capability quickly, but do so with clinical experts and patients at the forefront. I’m excited to join the team and contribute to achieving our goal of helping one million patients every day.”

The company said its founding CEO Dimitry Tran will continue to serve as director of the board.